Literature DB >> 10418352

Renal transplant recipients' and their physicians' expectations regarding return to work posttransplant.

S E Newton1.   

Abstract

The purpose of the study was to explore the return to work (RTW) expectations of adult renal transplant recipients and their transplant physicians. The design was a prospective survey. Data was collected from 25 adult end stage renal disease (ESRD) patients who were admitted to a large Midwestern transplant center for renal transplantation and the surgeons who performed their transplant operations. Self-administered questionnaires were completed pretransplant by the recipients and surgeons, and at 6 weeks posttransplant by the recipients. Recipients who were employed pretransplant and were more likely to expect to RTW posttransplant, did so at higher rates than recipients who were not employed pretransplant and had physicians who did not expect them to RTW. The results illustrate that posttransplant RTW expectations of both renal transplant recipients and their physicians, when assessed pretransplant, are often congruent and are indicative of recipient posttransplant vocational rehabilitation.

Entities:  

Mesh:

Year:  1999        PMID: 10418352

Source DB:  PubMed          Journal:  ANNA J        ISSN: 8750-0779


  3 in total

Review 1.  Measuring return to work.

Authors:  Radoslaw Wasiak; Amanda E Young; Richard T Roessler; Kathryn M McPherson; Mireille N M van Poppel; Johannes R Anema
Journal:  J Occup Rehabil       Date:  2007-10-11

Review 2.  Measures of patients' expectations about recovery: a systematic review.

Authors:  Shanil Ebrahim; Cindy Malachowski; Mostafa Kamal El Din; Sohail M Mulla; Luis Montoya; Sheena Bance; Jason W Busse
Journal:  J Occup Rehabil       Date:  2015-03

3.  Life and expectations post-kidney transplant: a qualitative analysis of patient responses.

Authors:  Emily L Tucker; Abigail R Smith; Mark S Daskin; Hannah Schapiro; Sabrina M Cottrell; Evelyn S Gendron; Peg Hill-Callahan; Alan B Leichtman; Robert M Merion; Stephen J Gill; Kayse Lee Maass
Journal:  BMC Nephrol       Date:  2019-05-16       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.